A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time

A case of tamoxifen-induced hypertriglyceridemia monitoring the changes in lipoprotein fractions over time

Abstract Background Tamoxifen, which is one of the selective estrogen receptor modulators (SERMs), can bring out life-threatening complication, e.g. hypertriglyceridemia-induced acute pancreatitis, although it is rare. We precisely report changes in lipoprotein metabolism before and after tamoxifen...

Full description

Bibliographic Details
Main Authors: Hayato Isobe, Masashi Shimoda, Yuki Kan, Fuminori Tatsumi, Yukino Katakura, Tomohiko Kimura, Atsushi Obata, Kenji Kohara, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Format: Article
Language:English
Published: BMC 2021-06-01
Series:BMC Endocrine Disorders
Subjects:
Tamoxifen
Hypertriglyceridemia
Lipoprotein fraction
Type 2 diabetes
Online Access:https://doi.org/10.1186/s12902-021-00780-z

Internet

https://doi.org/10.1186/s12902-021-00780-z

Similar Items